N Wilcken
Overview
Explore the profile of N Wilcken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
524
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Wilcken N, Hornbuckle J, Ghersi D
Cochrane Database Syst Rev
. 2003 Jun;
(2):CD002747.
PMID: 12804433
Background: Both chemotherapy and endocrine therapy can be used as treatments for metastatic breast cancer. Objectives: To review the evidence and determine whether chemotherapy or endocrine therapy has the most...
22.
Boyages J, Chua B, Taylor R, Bilous M, Salisbury E, Wilcken N, et al.
Br J Surg
. 2002 May;
89(6):789-96.
PMID: 12027994
Background: The 1998 St Gallen classification was devised to guide clinicians in the use of adjuvant systemic therapy for women with early breast cancer. In this study, the classification was...
23.
Wilcken N, Ghersi D, Brunswick C, Clarke M, Ganz P
Lancet
. 2000 Nov;
356(9237):1275-6.
PMID: 11072975
No abstract available.
24.
Stockler M, Wilcken N, Coates A
Eur J Cancer
. 1998 Feb;
33(13):2147-8.
PMID: 9470799
No abstract available.
25.
Wilcken N
N Engl J Med
. 1997 Sep;
337(13):937; author reply 937-8.
PMID: 9304057
No abstract available.
26.
Wilcken N
Aust N Z J Med
. 1992 Oct;
22(5):507; author reply 508-9.
PMID: 1445047
No abstract available.
27.
Wilcken N, Tattersall M
Cancer
. 1991 Sep;
68(6):1384-8.
PMID: 1831400
Two female patients with desmoid tumors (aggressive fibromatosis) showed tumor regression after endocrine therapy. In one patient, tumor response to tamoxifen has been maintained over several years of treatment. In...